Sellbyville, DE -- (SBWIRE) -- 03/19/2019 -- Veterinary Vaccines Market size is set to exceed USD 9.0 billion by 2025; according to a new research report by Global Market Insights. Food borne zoonotic diseases possess significant threat to human health as they are transferred from animals to humans during distinct stages of food chain or contact. According to European Food Safety Authority, around 320,000 people in Europe suffer from food borne zoonotic disease annually. The effects of food borne zoonotic disease may vary from mild symptoms to lethal conditions such as death. The increasing prevalence of food borne zoonotic diseases will stimulate growth of Veterinary vaccines market during the forecast period.

Increasing demand for animal food and animal products will significantly drive animal vaccines market growth over the forecast period. Reduction in meat prices in developing economies such as China is primary reason for increase in animal products consumption. As per WHO, annual meat production is estimated to reach 376 million tons by 2030. Livestock products are considered as desired food in majority of countries due to its nutritional value and taste. Aforementioned will considerably favor market growth in the future.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3117

Companion veterinary vaccines market is expected to reach USD 2,562.4 million by 2025. The trend of having animals as companions is on the rise across the globe. Diseases associated with companion animals may get transmitted to human population. To avoid spread of zoonotic diseases, vaccination of pets is mandatory. The rise in population of companion animals and increasing prevalence of zoonotic diseases will boost the growth of companion veterinary vaccines market.

Inactivated vaccines market is forecasted to expand at 4.2% CAGR during the projected timeframe. Advantages associated with inactivated vaccines such as no risk of reversion and easy inventory maintenance will boost industry growth. Moreover, inactivated vaccines can be administered to immunocompromised animal. Technological advancements in production coupled with superior immunity will favor segmental growth over forecast timeframe.

Parasitic vaccines market will reach revenue of USD 815.4 million by 2025. Parasitic infections in cattle and poultry lead to significant economic losses in animal farms. Improved efficacy to provide maximum immunity with minimal complications will favor segmental growth in the future. With various technological advances, parasitic vaccines market will witness tremendous growth in the future.

Oral vaccines held market share of 16.4% in 2018 and will reach USD 1,466.3 million by 2025 Growing occurrence of infectious diseases and the antimicrobial resistance to existing anti-infective agents are growth drivers of oral vaccines market. Ease of administration and increasing preference for oral vaccines coupled with various technological advancements will favor business growth over forecast timeframe.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3117

France market is expected to reach USD 450.2 million by 2025, owing to large population of farm and pet animals. According to International Federation for Animal Health Europe (IFAH-Europe), every one out of two houses in France has at least one companion animal. Vaccination in farm animals is a regular and widely practiced exercise across the nation. High intake of meat and chicken generates demand for various farm veterinary vaccines products leading to business growth in the future.

India market is forecasted to grow at 10.0% CAGR across the forecast timeframe. Rising awareness about animal health is predominant factor for increasing demand of animal vaccines products. India is home for more than 10% of global livestock population and ranks among the largest producers of cattle, chicken and fish. Favorable government policies and growing awareness in the country will increase adoption rate of veterinary vaccines, thereby propelling industry growth.

Some of the prominent players involved in Animal vaccines market are Boehringer Ingelheim Animal Health, Ceva Sante Animale, Dechra Pharmaceuticals, Durvet, Inc, Elanco, Henry Schein Animal Health, Hipra Animal Health Limited, Merck Animal Health, Neogen Corporation, and Zoetis. These firms adopt strategic initiatives including mergers and acquisitions, new product launch and geographical expansion. For instance, in August 2015, Dechra Pharmaceutical announced acquisition of genera dd, a Croatian company involved in development of animal health products. This acquisition enabled Dechra Pharmaceuticals to enter into veterinary vaccines segment.

Animal vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Veterinary Vaccines Market, by Animal Type
o Farm animals
o Poultry vaccines
o Cattle vaccines
o Swine vaccines
o Equine vaccines
o Aquaculture vaccines
o Companion animals
o Dog vaccines
o Cat vaccines

Veterinary Vaccines Market, by Technology
o Live attenuated vaccines
o Inactivated vaccines
o Toxoid Vaccines
o Recombinant Vaccines
o Other Vaccines

Veterinary Vaccines Market, by Infections
o Bacterial vaccines
o Viral vaccines
o Parasitic vaccines
o Fungal vaccines
o Others

Veterinary Vaccines Market, by Route of Administration
o Injection vaccines
o Oral vaccines
o Immersion/Spray vaccines
o Others

The above information is provided for the following regions and countries:
- North America
o U.S.
o Canada
- Europe
o Germany
o UK
o France
o Spain
o Italy
o Poland
o Netherlands
- Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
- Latin America
o Brazil
o Mexico
- Middle East & Africa
o South Africa
o Saudi Arabia